Our Partners & Members
We are a program of the International Federation of Psoriasis (IFPA), inspired by developments in the non-communicable diseases (NCD) policy agenda that calls on civil society to advocate for a people-centered and integrated response to psoriasis.
International federation of psoriasis associations
The International Federation of Psoriasis Associations (IFPA) is a non-profit organization uniting national and regional psoriasis associations from around the world. As the key global psoriasis advocacy organization, IFPA campaigns on behalf of all people with psoriasis and psoriatic arthritis. Most psoriasis associations across the world are IFPA members. IFPA aims to empower members, improve living conditions for patients, raise awareness of psoriasis and psoriatic arthritis and cooperate with fellow stakeholders.
The NCD Alliance is a unique civil society network, uniting 2,000 organizations in over 170 countries. Since 2009, the Alliance has worked to combat global non-communicable diseases by collaborating strategically with the World Health Organization, United Nations and national governments.
IFPA became the first NGO to represent psoriasis in the NCD Alliance in 2016. Through this relationship, the Global Psoriasis Coalition strengthens its advocacy work and existing links with the WHO and shining a spotlight not just on psoriasis but also on various comorbid NCDs such as diabetes and cardiovascular disease.
Almirall, Celgene, Leo Pharma, Lilly, Novartis, and SUN Pharma represent the Coalition’s current core membership. Learn more about the ways in which our members interact with IFPA and the broader landscape of psoriasis and psoriatic arthritis advocacy work in our Terms of Reference.